Interoperability

The clinical manifestations of COVID-19 are varied, and patients are known to have rapidly changing signs and symptoms that must be tracked with laboratory testing.

COVID-19 has revealed a lot about the world we live in. It has reinforced the possibilities that open up when we collaborate and come together, united towards a common cause; in this case, of defeating the spread of SARS-CoV-2 says Atif Al Braiki, CEO, Abu Dhabi Health Data Services LLC (Malaffi).

One of the more remarkable features of the NHS’s response to the coronavirus pandemic has been its rapid uptake of technology in the UK says director of international relations at NHS Confederation, Dr Layla McCay.

How healthcare providers can leverage interoperability across the care continuum for improved care coordination and patient empowerment. 

Michael Seres was an entrepreneur, patient advocate, husband and father of three. He died on 30 May 2020, in California, US, of a sepsis infection. This news not only shook the patient community, but also the global healthcare IT space.

A healthcare system in which stakeholders share, adopt and apply medical knowledge in real time enables improved care, accelerated workflows, streamlined business processes and a better balance of resources with demand.

Without cross-border co-operation the potential of personalised health cannot be realised, acccording to Bogi Eliasen, director at the Health Copenhagen Institute for Futures Studies and HIMSS Future50 leader, who will be speaking at HIMSS & Health 2.0 European Digital Event taking place 7-11 September.

Let’s invest in an interoperable health data system that connects all providers, hospitals, nursing homes, insurance companies, state and local governments, public health and patients who need access to medical records.

Dr. Michael von Bertele, non-executive director of Rutherford Health and Salisbury NHS foundation trust in the UK, writes about the ways we can build systems to avert critical situations, and be better prepared.  

 Privacy remains an important determinant of how technology is deployed, even during these times of COVID-19, argues HIMSS' chief clinical officer Dr. Charles Alessi.